/TSND.TO
TSND.TO Stock - TerrAscend Corp.
Healthcare|Drug Manufacturers - Specialty & GenericTSX
$1.00-9.09%
$0.10 (-9.09%) • Dec 22
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.96
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.40
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TSND.TO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.99 – $1.01
TARGET (TP)$1.15
STOP LOSS$0.92
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.99
52W High$2.00
52W Low$0.30
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $306.68M | $317.33M | $433.51M | $310.32M | $198.32M |
| Gross Profit | $149.96M | $159.70M | $160.66M | $170.92M | $26.34M |
| Gross Margin | 48.9% | 50.3% | 37.1% | 55.1% | 13.3% |
| Operating Income | $-17,106,000 | $-19,865,000 | $-41,530,133 | $50.91M | $-49,259,000 |
| Net Income | $-80,232,000 | $-91,101,000 | $-577,083,696 | $4.97M | $-155,123,000 |
| Net Margin | -26.2% | -28.7% | -133.1% | 1.6% | -78.2% |
| EPS | $-0.28 | $-0.33 | $-2.36 | $0.03 | $-1.04 |
Company Overview
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TSND.TOBeat Rate
13%
Last 16 quarters
Avg Surprise
-256.8%
EPS vs Estimate
Beats / Misses
2/14
Last 12 quarters
Latest EPS
$-0.06
Q4 2025
EPS Surprise History
Q1 24
-1042.9%
$-0.16vs$-0.01
Q2 24
-133.4%
$-0.06vs$-0.03
Q3 24
-20.0%
$-0.03vs$-0.03
Q4 24
-84.2%
$-0.07vs$-0.04
Q1 25
-266.7%
$-0.11vs$-0.03
Q2 25
-33.3%
$-0.04vs$-0.03
Q3 25
-387.7%
$-0.17vs$-0.03
Q4 25
-1214.2%
$-0.06vs$0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.01 | $-0.06 | -1214.2% | ✗ MISS |
Q3 2025 | Aug 7, 2025 | $-0.03 | $-0.17 | -387.7% | ✗ MISS |
Q2 2025 | May 7, 2025 | $-0.03 | $-0.04 | -33.3% | ✗ MISS |
Q1 2025 | Mar 6, 2025 | $-0.03 | $-0.11 | -266.7% | ✗ MISS |
Q4 2024 | Nov 6, 2024 | $-0.04 | $-0.07 | -84.2% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $-0.03 | $-0.03 | -20.0% | ✗ MISS |
Q2 2024 | May 9, 2024 | $-0.03 | $-0.06 | -133.4% | ✗ MISS |
Q1 2024 | Mar 14, 2024 | $-0.01 | $-0.16 | -1042.9% | ✗ MISS |
Q4 2023 | Nov 10, 2023 | $-0.02 | $-0.03 | -40.0% | ✗ MISS |
Q3 2023 | Aug 1, 2023 | $-0.03 | $-0.05 | -47.1% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.06 | $-0.13 | -115.5% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | $-0.05 | $-0.07 | -30.7% | ✗ MISS |
Q3 2022 | Sep 29, 2022 | $-0.07 | $-1.61 | -2104.2% | ✗ MISS |
Q2 2022 | Jun 29, 2022 | $-0.05 | $0.07 | +239.6% | ✓ BEAT |
Q1 2022 | Mar 30, 2022 | $-0.03 | $-0.10 | -218.4% | ✗ MISS |
Q4 2021 | Dec 30, 2021 | — | $-0.11 | — | — |
Q3 2021 | Sep 29, 2021 | $-0.03 | $0.36 | +1390.1% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about TSND.TO
What is TSND.TO's current stock price?
TerrAscend Corp. (TSND.TO) is currently trading at $1.00 per share. The stock has moved -9.09% today.
What is the analyst price target for TSND.TO?
No analyst price targets are currently available for this stock.
What sector is TerrAscend Corp. in?
TerrAscend Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the TSX exchange.
What is TSND.TO's market cap?
TerrAscend Corp. has a market capitalization of $0.31 billion, making it a small-cap company.
Does TSND.TO pay dividends?
No, TerrAscend Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACB.TO
Aurora Cannabis Inc.
$6.47
Mkt Cap: $0.4B
CPH.TO
Cipher Pharmaceuticals Inc.
$15.43
Mkt Cap: $0.4B
DR.TO
Medical Facilities Corporation
$15.48
Mkt Cap: $0.3B
EPRX.TO
Eupraxia Pharmaceuticals Inc.
$9.70
Mkt Cap: $0.3B
FRX.TO
Fennec Pharmaceuticals Inc.
$10.63
Mkt Cap: $0.3B
HLS.TO
HLS Therapeutics Inc.
$4.75
Mkt Cap: $0.1B
JUSH.CN
Jushi Holdings Inc.
$0.76
Mkt Cap: $0.1B
OGI.TO
OrganiGram Holdings Inc.
$2.64
Mkt Cap: $0.4B
WEED.TO
Canopy Growth Corporation
$1.84
Mkt Cap: $0.3B
XLY.TO
Auxly Cannabis Group Inc.
$0.15
Mkt Cap: $0.2B
Explore stocks similar to TSND.TO for comparison